Strs Ohio Vericel Corp Transaction History

Strs Ohio

$25.8 Billion
Q2 2025

A detailed history of Strs Ohio transactions in Vericel Corp stock. As of the latest transaction made, Strs Ohio holds 19,500 shares of VCEL stock, worth $675,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,500

Previous 18,200 7.14%

Holding current value

$675,480

Previous $812,000 2.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$37.92 - $45.7 $49,296 - $59,410	1,300 Added 7.14%	19,500 $829,000
Q1 2025 May 28, 2025	SELL	$44.5 - $61.8 $26,700 - $37,080	-600 Reduced 3.19%	18,200 $812,000
Q1 2024 May 13, 2024	SELL	$32.52 - $52.33 $58,536 - $94,194	-1,800 Reduced 8.74%	18,800 $977,000
Q3 2023 Oct 26, 2023	BUY	$31.69 - $39.25 $237,675 - $294,375	7,500 Added 57.25%	20,600 $690,000
Q2 2023 Jul 31, 2023	BUY	$29.0 - $38.37 $379,900 - $502,646	13,100 New	13,100 $492,000
Q1 2022 Apr 21, 2022	SELL	$31.69 - $43.29 $164,788 - $225,108	-5,200 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$35.2 - $52.6 $587,840 - $878,420	-16,700 Reduced 76.26%	5,200 $204,000
Q3 2021 Oct 22, 2021	SELL	$46.35 - $59.75 $13,905 - $17,925	-300 Reduced 1.35%	21,900 $1.07 Million
Q2 2021 Jul 26, 2021	SELL	$47.2 - $67.81 $202,960 - $291,583	-4,300 Reduced 16.23%	22,200 $1.17 Million
Q1 2021 Apr 23, 2021	BUY	$30.93 - $59.48 $163,929 - $315,244	5,300 Added 25.0%	26,500 $1.47 Million
Q4 2020 Jan 25, 2021	BUY	$18.53 - $31.5 $392,836 - $667,800	21,200 New	21,200 $654,000
Q2 2019 Jul 25, 2019	SELL	$15.01 - $18.89 $393,262 - $494,918	-26,200 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$9.6 - $14.6 $251,520 - $382,520	26,200 New	26,200 $254,000

Others Institutions Holding VCEL

# of Institutions

294

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.63B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account